Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.
about
A Role for Low Density Lipoprotein Receptor-Related Protein 1 in the Cellular Uptake of Tissue Plasminogen Activator in the LungsProteome profiling of lipopolysaccharide induced L6 rat skeletal muscle cells response to flavonoids from Scutellaria baicalensis Georgi.Neuroproteome changes after ischemia/reperfusion injury and tissue plasminogen activator administration in rats: a quantitative iTRAQ proteomics study.Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathwayAnnexin A2 heterotetramer: structure and functionIncreased annexin A1 and A2 levels in bronchoalveolar lavage fluid are associated with resistance to respiratory disease in beef calves.One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke.Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms.The inflammatory actions of coagulant and fibrinolytic proteases in disease.Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathwaysAnnexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity.Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis.Expression of CD11b (MAC-1) and CD162 (PSGL-1) on monocytes is decreased under conditions of deep hypothermic circulatory arrest.The Coagulant Factor Xa Induces Protease-Activated Receptor-1 and Annexin A2-Dependent Airway Smooth Muscle Cytokine Production and Cell Proliferation.Tissue-type plasminogen activator modulates macrophage M2 to M1 phenotypic change through annexin A2-mediated NF-κB pathway.Elevated levels of tissue plasminogen activator and E-selectin in male children with autism spectrum disorder.
P2860
Q28603536-C06FEC2F-EB37-4E37-9370-4CEA271BE6DFQ34332919-6647A223-5ABD-41AD-889A-4B5D94DA0CDBQ35176818-F4D45AC5-61A7-4C35-9D89-E3CD58A089A5Q35199467-72CA5F5D-D8D9-4AA6-8CC0-3789D86F2E1CQ36790362-6C74E924-E573-4827-ABE5-BDC4213BE117Q36793848-AE061E8F-2D84-4EFD-9E06-EA122F4536A5Q37668019-D92C73B9-8B4F-4772-9902-42E6730C3590Q38198639-A3389CB3-E726-46E8-BE28-87043D4A680CQ38423064-EC754C3C-9A0C-49B4-908D-3A1FDCADA7DBQ38448084-3A14ED32-784E-4C85-AEB4-4C160804BA03Q38914096-B7BC4E4E-9EA7-4727-AD03-5F55E3BE4BD7Q39001492-0295CA9C-656B-4F5A-BBD5-A6ED5056245AQ42718276-4D05ADF1-29EA-454A-9C65-92D06D3C4CABQ48165386-2541E14F-6578-4B1A-A27F-2708CAAB3D8EQ49896886-12F89437-5197-4F80-9653-1DAE11E0A188Q50210143-27C661ED-F044-4A2B-9E2F-D3E637F74D6B
P2860
Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tissue plasminogen activator a ...... 1b and integrin-linked kinase.
@ast
Tissue plasminogen activator a ...... 1b and integrin-linked kinase.
@en
type
label
Tissue plasminogen activator a ...... 1b and integrin-linked kinase.
@ast
Tissue plasminogen activator a ...... 1b and integrin-linked kinase.
@en
prefLabel
Tissue plasminogen activator a ...... 1b and integrin-linked kinase.
@ast
Tissue plasminogen activator a ...... 1b and integrin-linked kinase.
@en
P2093
P2860
P356
P1476
Tissue plasminogen activator a ...... 1b and integrin-linked kinase.
@en
P2093
P2860
P304
P356
10.1681/ASN.2011111123
P577
2012-06-07T00:00:00Z